EU approval boosts Bimzelx’s profile as innovative interleukin-17 inhibitor therapy: GlobalData EP News Bureau Jun 23, 2023 Bimzelx is set to become a blockbuster for the treatment of these debilitating, chronic conditions, with a global sales forecast…
